Medical/Pharmaceuticals
Gmax's GMA106, second generation obesity/T2DM/NASH mAb gives first in human dose
HANGZHOU, China, Nov. 11, 2021 /PRNewswire/ -- Gmax Biopharm today announces that the first dose of GMA106 was given to human subjects in a phase 1 study to investigate the safety, pharmacokinetics, and pharmacodynamics of this drug in the treatment of obesity. The study is a single dose, placeab...
2021-11-11 18:00
2028
Dr. Ivan Puah developed MDC-Sculpt(R) Lipo technique to achieve optimal liposuction results in patients
SINGAPORE, Nov. 11, 2021 /PRNewswire/ -- Dr Ivan Puah, Medical Director at Amaris B. Clinic, who has been performing liposuction, correction surgery and gynecomastia surgery for more than 15 years, has developed a liposuction technique called MDC-Sculpt®️ Lipo technique. This proprietary appro...
2021-11-11 16:52
2760
Everest Medicines and Gilead Sciences Jointly Announce Phase 2b Study of Sacituzumab Govitecan Conducted in China of Patients With Metastatic Triple-negative Breast Cancer Meets Primary Overall Response Rate Endpoint
SHANGHAI, Nov. 11, 2021 /PRNewswire/ -- Everest Medicines and Gilead Sciences, Inc. (Nasdaq: GILD) jointly announces today that Everest Medicines sponsored (HKEX 1952.HK) Phase2b EVER-132-001 study of sacituzumab govitecan (marketed as Trodelvy® in the United States) met its primary endpoint o...
2021-11-11 08:05
4500
Luye Pharma Grants Zambon Exclusive Commercialization Rights to Its Innovative Alzheimer's Disease Treatment Rivastigmine Multi-Day Transdermal Patch in Switzerland
BASEL, Switzerland, Nov. 10, 2021 /PRNewswire/ -- Luye Pharma Group (Luye Pharma) today announced that its subsidiary Luye Pharma Switzerland AG has entered into an agreement with Zambon Switzerland (Zambon), under which the company grants Zambon exclusive rights to commercialize Rivastigmine Mul...
2021-11-10 23:38
4986
Recruitment for the dosimetry phase of Clarity's Cu-64/Cu-67 SAR-bisPSMA theranostic prostate cancer trial completed
* Clarity Pharmaceuticals completes recruitment for the initial dosimetry phase of its SAR-bisPSMA theranostic clinical trial SECuRE (NCT04868604)[1] investigating Targeted Copper Theranostics (TCT) in patients with metastatic castrate-resistant prostate cancer (mCRPC). * Dosimetry data is be...
2021-11-10 22:06
2770
IASO Biotherapeutics and Innovent Biologics to Present New BCMA CAR-T Cell Therapy Data in Oral Presentation at ASH 2021
SAN JOSE, Calif., NANJING, China and SHANGHAI, Nov. 10, 2021 /PRNewswire/ --
IASO Biotherapeutics("IASO Bio")
2021-11-10 21:30
2259
Care Group Acquires Pukekohe Family Health Care to Become Largest Provider of Primary Care in East Auckland
AUCKLAND, New Zealand, Nov. 10, 2021 /PRNewswire/ -- Care Group, a renowned provider and integrator of health services, has acquired Pukekohe Family Health Care (PFHC), a large general practice based in Central Pukekohe. The latest acquisition is in sync with the group's vision to build community...
2021-11-10 21:13
3092
David C. Dvorak is THINK Surgical's New Executive Chairman of the Board of Directors
FREMONT, Calif., Nov. 10, 2021 /PRNewswire/ -- THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced the appointment ofDavid C. Dvorak as the Executive Chairman of its Board of Directors. Mr. Dvorak's decades of experience in the medical device industry, ...
2021-11-10 21:00
1969
Lianhua Qingwen Sent to People for Covid-19 Containment by Cambodian Government
PHNOM PENH, Cambodia, Nov. 10, 2021 /PRNewswire/ -- On Sunday, 600 local families in Veal Veaeng District, Pursat Province,Cambodia, got Lianhua Qingwen Capsules, produced by Yiling Pharmaceutical, from Suy Sem, the Cambodian Minister of Mines and Energy, also president of the Cambodian central ...
2021-11-10 20:07
3148
I-Mab and Jumpcan Announce Strategic Commercial Partnership on Eftansomatropin Alfa
* The partnership brings together the strengths of an innovative global biotech and a domestic leading pharmaceutical company specialized in and committed to pediatric medicines to accelerate the commercialization of eftansomatropin alfa * Jumpcan will pay I-Mab for a total of up to RMB 2.016...
2021-11-10 17:30
2625
Hummingbird Bioscience Announces Trials in Progress Poster Presentation at the Society for Immunotherapy of Cancer 2021 36th Annual Meeting
HOUSTON, Nov. 10, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, today announced a Trials in Progress poster presentation outlining the Phase 1 clinical trial design for HMBD-002, a ...
2021-11-10 17:00
2038
AffaMed Therapeutics Announces the Establishment of AffaMed Digital to Advance Digital Medicines
SHANGHAI, Nov. 10, 2021 /PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a global clinical-stage therapeutic company dedicated to developing and commercializing transformative pharmaceutical, digital and surgical products that address critical unmet medical needs in ophthalmic, neurological and ...
2021-11-10 15:00
3202
OMRON Launches World's Fastest CT X-ray Inspection with New VT-X750-V3 AXI System
KYOTO, Japan, Nov. 10, 2021 /PRNewswire/ -- OMRON Corporation based in Kyoto, Japan, has announced the development of a new VT-X750-V3 system, the world's fastest (*1) CT-type X-ray inspection device (*2) to date, and said it will be released globally onNovember 20. The VT-X750-V3 delivers advanc...
2021-11-10 14:00
2033
LifeWave Held Amplify Summer Summit 2021
TOKYO, Nov. 10, 2021 /PRNewswire/ -- LifeWave, a U.S.-based global health technology company, hosted a summer conference onAugust 21 and 22, 2021. The conference, dubbedAmplify, focused on LifeWave's products and the company's business opportunities. It was held virtually because of recommendatio...
2021-11-10 11:18
3367
Ascletis Announces Approval of Phase II Clinical Trial of ASC22 (Envafolimab) by China NMPA for Immune Restoration/Functional Cure of HIV-1 Infected Patients
HANGZHOU, China and SHAOXING, China, Nov. 10, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces the approval of the Phase II clinical trial of ASC22 (Envafolimab) by China National Medical Products Administration (NMPA) for the proposed new indication of immune restoration/fu...
2021-11-10 08:30
3970
Smith+Nephew establishes its first Medical Education Centre for the Asia Pacific region in Singapore
LONDON, Nov. 10, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the
global medical technology business, today announces its first dedicated Medical
Education Centre to support customers across theAsia Pacific region.
2021-11-10 08:04
5919
Prenetics Announces Strong First Half 2021 Financial Results as Company Progresses Towards a U.S. Nasdaq Listing in Partnership with Artisan Acquisition Corp.
* Revenue reached US$136.5 million, up 1,039% year-over-year * Adjusted EBITDA was US$31.5 million, increased by US$34.6 million year-over-year * Prenetics has publicly filed a registration statement on Form F-4 with the SEC in connection with its proposed business combination with Artisan ...
2021-11-10 07:34
3111
I-Mab and ABL Bio Report Preclinical Data of 4-1BB-targeting Bispecific Antibodies at 2021 SITC
* Preclinical data of TJ-CD4B/ABL111 and TJ-L14B/ABL503 demonstrate targeted safety profile and enhanced anti-tumor activity * Both studies are undergoing phase 1 clinical trials in the United States SHANGHAI and GAITHERSBURG, Md. and SEONGNAM, South Korea, Nov. 9, 2021 /PRNewswire/ -- I-Mab ...
2021-11-09 21:05
3261
INOVIO Receives U.S. FDA Authorization to Proceed with INNOVATE Phase 3 Segment for its COVID-19 Vaccine Candidate, INO-4800, in the U.S.
FDA Lifts Partial Clinical Hold on INNOVATE Phase 3 Segment PLYMOUTH MEETING, Pa., Nov. 9, 2021 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to help protect people from infectious diseases and treat cancer and HPV-a...
2021-11-09 21:00
3897
Ceres Nanosciences Establishes Nine Wastewater-based COVID-19 Surveillance Centers of Excellence Under NIH RADx Initiative
MANASSAS, Va., Nov. 9, 2021 /PRNewswire/ -- Ceres Nanosciences (Ceres), a privately held company that makes innovative products to improve life science research and diagnostic testing, is announcing the establishment of nine wastewater-based epidemiology centers of excellence, as part of theApril...
2021-11-09 20:55
3468
Week's Top Stories
Most Reposted
Responsible Fintech Institute Appoints Four Executive Fellows and Elevates Distinguished Professor Patrick H. M. Loh to Co-Founder
[Picked up by 279 media titles]
2026-09-29 09:00
HLB's Flagship CIO Fund Launched with Strategic Alliance with Lombard Odier
[Picked up by 278 media titles]
2026-09-28 23:04
Malaysia Calls for Shift from Halal-Certified to Halal-Competitive as ASEAN Targets USD5 Trillion Global Halal Economy
[Picked up by 277 media titles]
2026-09-25 14:45
Nuix Recognised as a RiskTech100® 2027 Disruptor by Chartis Research
[Picked up by 274 media titles]
2026-09-25 08:30Allianz Partners unveils next-generation travel insurance platform to help partners navigate changing landscape
[Picked up by 269 media titles]
2026-09-28 07:30
Most Read
Brightray Signs Prefabricated Module Sales Framework Agreement for Planned 40MW AI Data Center Project in Macao
2026-09-25 20:30
14208
Envision Energy Secures TÜV SÜD Certificate for Wind Farm Control System, Strengthening Long-Term Resilience for Future Energy Systems
2026-09-25 20:11
12892
ULTRALOQ Launches Next-Generation Smart Lock Collection: Refining Home Entry with Natural, Intelligent and Trusted Access Solutions
2026-09-26 02:46
12002
